151 related articles for article (PubMed ID: 38166744)
21. Sex-specific prognostic effect of CD66b-positive tumor-infiltrating neutrophils (TANs) in gastric and esophageal adenocarcinoma.
Quaas A; Pamuk A; Klein S; Quantius J; Rehkaemper J; Barutcu AG; Rueschoff J; Zander T; Gebauer F; Hillmer A; Buettner R; Schroeder W; Bruns CJ; Löser H; Schoemig-Markiefka B; Alakus H
Gastric Cancer; 2021 Nov; 24(6):1213-1226. PubMed ID: 34009535
[TBL] [Abstract][Full Text] [Related]
22. APOBEC2 negatively regulates myoblast differentiation in muscle regeneration.
Ohtsubo H; Sato Y; Suzuki T; Mizunoya W; Nakamura M; Tatsumi R; Ikeuchi Y
Int J Biochem Cell Biol; 2017 Apr; 85():91-101. PubMed ID: 28215905
[TBL] [Abstract][Full Text] [Related]
23. Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma.
Zhai Y; Liu X; Huang Z; Zhang J; Stalin A; Tan Y; Zhang F; Chen M; Shi R; Huang J; Wu C; Wu Z; Lu S; You L; Wu J
Sci Rep; 2023 Jan; 13(1):1373. PubMed ID: 36697459
[TBL] [Abstract][Full Text] [Related]
24. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma.
Zhou R; Peng N; Li W
Front Immunol; 2022; 13():964919. PubMed ID: 36059494
[TBL] [Abstract][Full Text] [Related]
25. HBV triggers APOBEC2 expression through miR‑122 regulation and affects the proliferation of liver cancer cells.
Li A; Wu J; Zhai A; Qian J; Wang X; Qaria MA; Zhang Q; Li Y; Fang Y; Kao W; Song W; Zhang Z; Zhang F
Int J Oncol; 2019 Nov; 55(5):1137-1148. PubMed ID: 31485598
[TBL] [Abstract][Full Text] [Related]
26. Increased
Zhaoran S; Linnebacher CS; Linnebacher M
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046730
[TBL] [Abstract][Full Text] [Related]
27. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma.
Song Z; Su M; Li X; Xie J; Han F; Yao J
BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437
[TBL] [Abstract][Full Text] [Related]
28. A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma.
Liu Z; Liu H; Wang Y; Li Z
BMC Gastroenterol; 2022 Oct; 22(1):435. PubMed ID: 36241983
[TBL] [Abstract][Full Text] [Related]
29. Identification and characterization of nucleotide metabolism and neuroendocrine regulation-associated modification patterns in stomach adenocarcinoma with auxiliary prognostic assessment and immunotherapy response prediction.
Zhang Y; Zeng L; Lin D; Chang G; Zeng Y; Xia Y
Front Endocrinol (Lausanne); 2022; 13():1076521. PubMed ID: 36726460
[TBL] [Abstract][Full Text] [Related]
30. Solute carrier family 35 member A2 (SLC35A2) is a prognostic biomarker and correlated with immune infiltration in stomach adenocarcinoma.
Huang Z; Yang H; Lao J; Deng W
PLoS One; 2023; 18(7):e0287303. PubMed ID: 37467193
[TBL] [Abstract][Full Text] [Related]
31. eEF2K as a novel metastatic and prognostic biomarker in gastric cancer patients.
Jiang M; Qi L; Jin K; Li L; Wu Y; Song D; Gan J; Huang M; Li Y; Song C
Pathol Res Pract; 2021 Sep; 225():153568. PubMed ID: 34352439
[TBL] [Abstract][Full Text] [Related]
32. WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma.
Yuan Q; Zhou Q; Ren J; Wang G; Yin C; Shang D; Xia S
Cancer Med; 2021 Jun; 10(12):4004-4016. PubMed ID: 33982398
[TBL] [Abstract][Full Text] [Related]
33. CFP is a prognostic biomarker and correlated with immune infiltrates in Gastric Cancer and Lung Cancer.
Cui G; Geng L; Zhu L; Lin Z; Liu X; Miao Z; Jiang J; Feng X; Wei F
J Cancer; 2021; 12(11):3378-3390. PubMed ID: 33976747
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of expression signature and immune microenvironment signature of biomarker Endothelin Receptor Type A in stomach adenocarcinoma.
Wang Z; Wang K; Yu X; Chen M; Du Y
J Cancer; 2022; 13(7):2086-2104. PubMed ID: 35517422
[No Abstract] [Full Text] [Related]
35. High Expression of ERK-related RASGRF2 predicts Poor prognosis in patients with Stomach Adenocarcinoma and correlates with M2 macrophage.
Du Y; Wang Z; Wan W
J Cancer; 2021; 12(23):7177-7189. PubMed ID: 34729119
[No Abstract] [Full Text] [Related]
36. The circadian clock is associated with prognosis and immune infiltration in stomach adenocarcinoma.
Huang Z; He A; Wang J; Lu H; Zhang R; Wu L; Feng Q
Aging (Albany NY); 2021 Jun; 13(12):16637-16655. PubMed ID: 34162762
[TBL] [Abstract][Full Text] [Related]
37. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
38. IRF7 is a Prognostic Biomarker and Associated with Immune Infiltration in Stomach Adenocarcinoma.
Guo L; Fang T; Jiang Y; Liu D
Int J Gen Med; 2021; 14():9887-9902. PubMed ID: 34938108
[TBL] [Abstract][Full Text] [Related]
39. Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients.
Zha Z; Zhang P; Li D; Liu G; Lu L
Dis Markers; 2021; 2021():8895723. PubMed ID: 33680217
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination.
You W; Ouyang J; Cai Z; Chen Y; Wu X
Front Immunol; 2022; 13():827506. PubMed ID: 35874675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]